Works matching DE "EVEROLIMUS"


Results: 1059
    1
    2
    3

    Farklı Klinik ve Yönetim ile İntrakardiyak Tümörlü Üç Yenidoğan Olgusu.

    Published in:
    Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2025, v. 78, p. 90
    By:
    • Kaymaz, Doğan;
    • Torlak, Ezgi Ünlü;
    • Yılmaz, Yağmur Erkol;
    • Ramoğlu, Mehmet;
    • Okulu, Emel;
    • Özdemir, Sonay İncesoy;
    • Erdeve, Ömer;
    • Uçar, Tayfun;
    • Atasay, Begüm;
    • Taçyıldız, Nurdan;
    • Ünal, Emel;
    • Arsan, Saadet
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 124, n. 1, p. 33, doi. 10.1007/s11060-015-1812-3
    By:
    • Graillon, Thomas;
    • Defilles, Céline;
    • Mohamed, Amira;
    • Lisbonis, Christophe;
    • Germanetti, Anne-Laure;
    • Chinot, Olivier;
    • Figarella-Branger, Dominique;
    • Roche, Pierre-Hugues;
    • Adetchessi, Tarek;
    • Fuentes, Stéphane;
    • Metellus, Philippe;
    • Dufour, Henry;
    • Enjalbert, Alain;
    • Barlier, Anne
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.

    Published in:
    Oncology, 2016, v. 90, n. 6, p. 339, doi. 10.1159/000445978
    By:
    • Heilmann, andreas M.;
    • Subbiah, Vivek;
    • Wang, Kai;
    • Sun, James X.;
    • Elvin, Julia a.;
    • Chmielecki, Juliann;
    • Sherman, Steven I.;
    • Murthy, Ravi;
    • Busaidy, Naifa L.;
    • Subbiah, Ishwaria;
    • Yelensky, Roman;
    • Nangia, Chaitali;
    • Vergilio, Jo-anne;
    • Khan, Saad a.;
    • Erlich, Rachel L.;
    • Lipson, Doron;
    • Ross, Jeffrey S.;
    • Miller, Vincent a.;
    • Shah, Manisha H.;
    • ali, Siraj M.
    Publication type:
    Article
    19

    Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.

    Published in:
    Oncology, 2015, v. 89, n. 6, p. 319, doi. 10.1159/000437230
    By:
    • Pouget, Mélanie;
    • abrial, Catherine;
    • Planchat, Eloise;
    • Van Praagh, Isabelle;
    • arbre, Marie;
    • Kwiatkowski, Fabrice;
    • Dubray-Longeras, Pascale;
    • Devaud, Hervé;
    • Dohou, Joyce;
    • Herviou, Pauline;
    • Mahammedi, Hakim;
    • Durando, Xavier;
    • Chollet, Philippe;
    • Mouret-Reynier, Marie-ange
    Publication type:
    Article
    20
    21
    22

    Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project).

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 1, p. 145, doi. 10.3390/jcm14010145
    By:
    • Fort-Casamartina, Eduard;
    • Pernas, Sonia;
    • Otero, Sara;
    • Mate, Paula;
    • Gonzalo, Núria;
    • Narváez, Sonia;
    • Rigo-Bonnin, Raúl;
    • Padró-Miquel, Ariadna;
    • Teulé, Àlex;
    • Garcia del Muro, Xavier;
    • Peiró, Inma;
    • Arribas, Lorena;
    • Esteve, Anna;
    • Gonzalez, Andrea;
    • Rey, Montse;
    • Clopés, Ana;
    • Fontanals, Sandra;
    • Muñoz, Carme
    Publication type:
    Article
    23

    Stepwise Reduction of Mycophenolate Mofetil with Conversion to Everolimus for the Treatment of Active BKV in Kidney Transplant Recipients: A Single-Center Experience in Vietnam.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7297, doi. 10.3390/jcm11247297
    By:
    • Kien, Truong Quy;
    • Kien, Nguyen Xuan;
    • Thang, Le Viet;
    • Nghia, Phan Ba;
    • Van, Diem Thi;
    • Duc, Nguyen Van;
    • Ha, Do Manh;
    • Dung, Nguyen Thi Thuy;
    • Ha, Nguyen Thi Thu;
    • Loan, Vu Thi;
    • Vinh, Hoang Trung;
    • Manh, Bui Van;
    • Su, Hoang Xuan;
    • Tien, Tran Viet;
    • Rostaing, Lionel;
    • Toan, Pham Quoc
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Antimycobacterial Effects of Everolimus in a Human Granuloma Model.

    Published in:
    Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2043, doi. 10.3390/jcm9072043
    By:
    • Ashley, David;
    • Hernandez, Joshua;
    • Cao, Ruoqiong;
    • To, Kimberly;
    • Yegiazaryan, Aram;
    • Abrahem, Rachel;
    • Nguyen, Timothy;
    • Owens, James;
    • Lambros, Maria;
    • Subbian, Selvakumar;
    • Venketaraman, Vishwanath
    Publication type:
    Article
    30
    31
    33
    34
    35
    36

    Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma.

    Published in:
    Oncologist, 2023, v. 28, n. 1, p. 59, doi. 10.1093/oncolo/oyac142
    By:
    • Bergerot, Cristiane;
    • Rha, Sun Young;
    • Pal, Sumanta;
    • Koralewski, Piotr;
    • Stroyakovskiy, Daniil;
    • Alekseev, Boris;
    • Parnis, Francis;
    • Castellano, Daniel;
    • Lee, Jae Lyun;
    • Sunela, Kaisa;
    • Ciuleanu, Tudor;
    • Heng, Daniel;
    • Glen, Hilary;
    • Wang, Jinyi;
    • Bennett, Lee;
    • Pan, Janice;
    • O'Hara, Karen;
    • Puente, Javier
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45

    A Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 925, doi. 10.1634/theoncologist.2020-0367
    By:
    • El Dika, Imane;
    • Mayer, Robert J.;
    • Venook, Alan P.;
    • Capanu, Marinela;
    • LaQuaglia, Michael P.;
    • Kobos, Rachel;
    • O'Neill, Allison F.;
    • Chou, Joanne F.;
    • Ly, Michele;
    • Ang, Celina;
    • O'Reilly, Eileen M.;
    • Gordan, John D.;
    • Abou‐Alfa, Ghassan K.
    Publication type:
    Article
    46

    Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor‐Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care‐BC): A Randomized Controlled Phase III Trial.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e223, doi. 10.1634/theoncologist.2019-0382
    By:
    • Niikura, Naoki;
    • Nakatukasa, Katsuhiko;
    • Amemiya, Takeshi;
    • Watanabe, Ken‐ichi;
    • Hata, Hironobu;
    • Kikawa, Yuichiro;
    • Taniike, Naoki;
    • Yamanaka, Takashi;
    • Mitsunaga, Sachiyo;
    • Nakagami, Kazuhiko;
    • Adachi, Moriyasu;
    • Kondo, Naoto;
    • Shibuya, Yasuyuki;
    • Hayashi, Naoki;
    • Naito, Mariko;
    • Kashiwabara, Kosuke;
    • Yamashita, Toshinari;
    • Umeda, Masahiro;
    • Mukai, Hirofumi;
    • Ota, Yoshihide
    Publication type:
    Article
    47
    48
    49
    50